June 27th 2025
Lipocene anticipates the phase 3 trial data will support an NDA submission for LPCN 1154 to treat PPD in mid-2026, the company said.
Health Status, Not Age, Associated with Rise in Adverse Pregnancy Outcomes in the US
February 27th 2023ACC 2023. Increasing rates of adverse pregnancy outcome over the last decade are largely attributable to a woman’s health status before she gets pregnant, rather than age, according to new research.